|Bid||0.00 x 3100|
|Ask||0.00 x 2900|
|Day's Range||5.07 - 5.20|
|52 Week Range||3.51 - 6.15|
|Beta (3Y Monthly)||1.32|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 2, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.50|
DEERFIELD, Ill., April 18, 2019 -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced it plans to release financial results from the.
Zimmer Biomet and RTI Surgical Holdings, Inc. today announced they are donating a supply of dental implants and wound care products to the American Academy of Implant Dentistry Foundation (AAIDF) for an initiative benefitting veterans of the United States Armed Forces. The AAIDF is the charitable arm of the American Academy of Implant Dentistry, a Chicago-based professional organization that advances the science and practice of implant dentistry through education and research support and serves as the credentialing standard for implant dentistry. Under the new partnership, Zimmer Biomet, through its Dental division, donated thousands of collagen wound care products that will be used in socket preservation procedures preparing veterans to receive dental implant therapy.
Decision may help more patients access RTI’s SImmetry® Sacroiliac Joint Fusion System, a minimally invasive surgical solution for sacroiliac (SI) joint dysfunction Blue Cross.
DEERFIELD, Ill., April 03, 2019 -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, is the Platinum Partner at the International Society for the.
DEERFIELD, Ill., March 20, 2019 -- RTI Surgical Holdings, Inc. (NASDAQ: RTIX), a global surgical implant company, today announced it enrolled the first patient in its Clinical.
RTI Surgical Holdings, Inc. (RTIX), a global surgical implant company, today announced the appointment of Jeffrey C. Lightcap to its Board of Directors, effective immediately. Mr. Lightcap has significant experience in helping drive growth in medical technology companies. Prior to HealthCor, Mr. Lightcap served as a Senior Managing Director at JLL Partners, a leading middle-market private equity firm. Prior to JLL Partners, Mr. Lightcap served as a Managing Director at Merrill Lynch & Co., Inc. Mr. Lightcap currently serves as Chairman of the Board of Directors of Corindus Vascular Robotics, Inc. and serves on the Board of Directors of Heartflow, Inc. and several smaller private companies.
RTI Surgical Holdings, Inc. (RTIX), a global surgical implant company, today announced it has completed the acquisition of Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology. Paradigm Spine’s primary product is the coflex® Interlaminar Stabilization® device. “The acquisition of Paradigm aligns with RTI’s growth strategy focused on investing in differentiated products and building scale within our spine business,” said Camille Farhat, President and CEO, RTI Surgical.
RTI Surgical, Inc. (RTIX), a global surgical implant company, today announced its shareholders have voted to approve completion of the company’s previously announced acquisition of Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology. The final voting results have been disclosed on a Form 8-K filed with the Securities and Exchange Commission. RTI Surgical anticipates closing the acquisition on Friday, March 8, 2019.
RTI Surgical Inc is a surgical implant company. It processes donated human musculoskeletal and other tissue, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera, dermal tissue and bovine and porcine animal tissue. Warning! GuruFocus has detected 4 Warning Sign with RTIX.
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. Unfortunately, there are also plenty of examples of share pricesRead More...
ALACHUA, Fla., Feb. 28, 2019 -- RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, reported operating results for the fourth quarter and full year of 2018..
RTI Surgical, Inc. (RTIX), a global surgical implant company, today announced it plans to release financial results from the fourth quarter and full year 2018 on Thursday, February 28, 2019, prior to the market open. RTI Surgical is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. RTI is accredited in the U.S. by the American Association of Tissue Banks and is a member of AdvaMed.
Want to help shape the future of investing tools? Participate in a short research study and receive a 6-month subscription to the award winning Simply Wall St research tool (valued Read More...
RTI Donor Services (RTIDS), a nonprofit organization dedicated to providing responsible stewardship of the gift of tissue donation, and Versiti, a national leader in blood health innovation and transplantation services, are pleased to announce their participation with the Donate Life Float in the 2019 Rose Parade®, taking place in Pasadena, Calif. on January 1, 2019. The Donate Life float is part of a national initiative to help share the importance of organ, eye and tissue donation. RTIDS is honored to be sponsoring tissue recipient Molly Blackwood as a walker on the 2019 float.
Decision may help more patients access RTI’s SImmetry® Sacroiliac Joint Fusion System, a minimally invasive surgical solution for sacroiliac joint dysfunction
NEW YORK, Nov. 14, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
RTI Surgical, Inc. (RTIX), a global surgical implant company, and Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology, today announced that they have entered into a definitive agreement whereby RTI will acquire all outstanding equity interest of Paradigm Spine in a cash and stock transaction valued at up to $300 million, consisting of $150 million at closing plus potential future milestone payments. RTI believes this transaction underscores its significant progress executing against its strategic transformation to reduce complexity, drive operational excellence and accelerate growth. Under the terms of the agreement, RTI shall pay $100 million in cash and 10,729,614 shares of RTI common stock at closing.
RTI Surgical (RTIX) delivered earnings and revenue surprises of 50.00% and -1.46%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Alachua, Florida-based company said it had profit of 4 cents. Earnings, adjusted for one-time gains and costs, were 3 cents per share. The orthopedic implant maker posted revenue ...